Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 2 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar OKwarrior (26.43) Submitted: 6/9/2014 1:38:50 AM : Underperform Start Price: $12.38 FLML Score: -8.13

declining revenues, negative cash flows. Not going to outpace the market.

Featured Broker Partners


Advertisement